Cordance Medical and EXACT Therapeutics Announce Early Encouraging Data in Brain Cancer Mice Model January 28, 2025
Abyssinia Biosciences and Cordance Medical announce a partnership to explore the diagnostic and therapeutic utility of focused ultrasound technology in combination with soluble oligomer targeting mAbs January 23, 2025
Cordance Medical Founder to Speak on Therapeutic Ultrasound Innovations at PMWC 2025 January 17, 2025
Cordance Medical Secures European Union Patent for Groundbreaking Blood-Brain Barrier Technology December 19, 2024
Cordance Medical Receives NIH/NCI SBIR Phase I Grant to Advance Non-Invasive Focused Ultrasound for Brain Tumor Liquid Biopsy in Glioma Models September 19, 2024
Cordance Medical Announces Triple Patent Grant to Revolutionize Treatment of Brain Diseases with its Innovative NeuroAccess Platform April 17, 2024
Cordance Medical Announces Agreement with Stanford Medicine’s Airan and Williams Labs for Precision Neuropsychiatry with Ultrasonic Drug Uncaging Technology December 6, 2023